MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-08-2023
Horizon Therapeutics Public Limited Company Total Inventories 2011-2026 | HZNP
Annual Total Inventories Horizon Therapeutics Public Limited Company
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 170 M | 226 M | 75.3 M | 53.8 M | 50.8 M | 61.7 M | 175 M | 18.4 M | 16.9 M | 8.7 M | 5.24 M | 1.2 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 226 M | 1.2 M | 71.8 M |
Quarterly Total Inventories Horizon Therapeutics Public Limited Company
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 170 M | 164 M | 170 M | 190 M | - | 227 M | 226 M | 237 M | 259 M | 238 M | 75.3 M | 75.3 M | 75.3 M | 75.3 M | 53.8 M | 53.8 M | 53.8 M | 53.8 M | 50.8 M | 50.8 M | 50.8 M | 50.8 M | 61.7 M | 61.7 M | 61.7 M | 61.7 M | 175 M | 175 M | 175 M | 175 M | 18.4 M | 18.4 M | 18.4 M | 18.4 M | 16.9 M | 16.9 M | 16.9 M | 16.9 M | 8.7 M | 8.7 M | 8.7 M | 8.7 M | 5.24 M | 5.24 M | 5.24 M | 5.24 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 259 M | 1.2 M | 76.5 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aptorum Group Limited
APM
|
39.1 K | $ 0.81 | 0.15 % | $ 4.42 M |  China |
 |
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M |  USA |
 |
BioMarin Pharmaceutical
BMRN
|
1.23 B | $ 61.58 | -1.66 % | $ 11.7 B | USA |
 |
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | USA |
 |
Axsome Therapeutics
AXSM
|
27.9 M | $ 165.14 | -2.83 % | $ 8.22 B | USA |
 |
CASI Pharmaceuticals
CASI
|
1.91 M | $ 0.31 | -61.59 % | $ 42.2 M | USA |
 |
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | USA |
 |
Catalyst Biosciences
CBIO
|
4.28 M | $ 12.21 | -3.48 % | $ 804 M | USA |
 |
BeiGene, Ltd.
BGNE
|
495 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Biogen
BIIB
|
2.17 B | $ 191.78 | -1.72 % | $ 28.1 B | USA |
 |
Baudax Bio
BXRX
|
5 M | - | 0.59 % | $ 63 K | USA |
 |
Amneal Pharmaceuticals
AMRX
|
612 M | $ 14.64 | -0.17 % | $ 4.52 B | USA |